Atlas Trials

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Clinical trial NCT02883153 · COMPLETED

Trial details

NCT number
NCT02883153
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2015-12-01
Primary completion
2017-06-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.